Lung Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who are able to give informed consent and agree to follow the study requirements
- People diagnosed with advanced non-small cell lung cancer
- People currently receiving immune checkpoint inhibitor treatment, specifically a type of drug known as an anti-PD-1/PD-L1 monoclonal antibody
- People who are able to provide tumor tissue samples (either fresh samples taken before and after treatment, or stored tissue from within the past year) along with a blood sample
- People whose general physical fitness is rated at ECOG level 0 or 1, meaning they are able to carry out normal daily activities with little or no restriction (confirm with trial site)
- People who have at least one tumour that can be measured using standard imaging guidelines
- People with a life expectancy of at least 12 weeks
- People whose blood counts and organ function (including liver and blood clotting measures) meet the required levels within 7 days before treatment begins (confirm with trial site for specific values)
Who may not be able to join:
- People who have another active cancer, except for certain early-stage or treated skin or cervical cancers that have not returned within the past 5 years
- People who have previously received approved systemic anti-tumour immunotherapy before entering the study
- People with a history of interstitial lung disease, non-infectious pneumonia, or uncontrolled conditions such as diabetes, high blood pressure, pulmonary fibrosis, or acute lung disease
- People with severe ongoing or active infections requiring antibiotics, antifungal, or antiviral treatment, including tuberculosis
- People with a known HIV infection, or who have previously had a stem cell transplant or organ transplant
- People whom the study investigator believes may not be able to reliably follow the study requirements throughout the trial period
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Objective response rate (ORR); Progression-free survival (PFS)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 15 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.